Our FDA study process , whether specifically done in the US or with data gained thus far, will be quite different. The product is far superior. AVR wins the approval. Game over. Takeover before FDA granted or even study commenced remains a real possibility.
- Forums
- ASX - By Stock
- AVR
- Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger, page-128
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.50 |
Change
-0.400(3.10%) |
Mkt cap ! $264.2M |
Open | High | Low | Value | Volume |
$12.71 | $12.71 | $12.30 | $131.3K | 10.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 85 | $11.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.50 | 276 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 85 | 11.620 |
1 | 1500 | 11.610 |
1 | 500 | 11.050 |
1 | 100 | 11.000 |
1 | 500 | 10.990 |
Price($) | Vol. | No. |
---|---|---|
12.500 | 276 | 1 |
13.400 | 500 | 1 |
13.440 | 246 | 1 |
13.450 | 73 | 1 |
14.440 | 25 | 1 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |